- Trials with a EudraCT protocol (815)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
815 result(s) found for: prostate cancer.
Displaying page 9 of 41.
EudraCT Number: 2015-003397-33 | Sponsor Protocol Number: IRST185.02 | Start Date*: 2015-10-08 | |||||||||||
Sponsor Name:ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS | |||||||||||||
Full Title: 68Ga-PSMA HBED-PET/CT in the evaluation of the biochemical relapse in patients with a history of prostate cancer radically treated. | |||||||||||||
Medical condition: prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002021-28 | Sponsor Protocol Number: PLX124-04 | Start Date*: 2020-09-24 | |||||||||||||||||||||
Sponsor Name:Plexxikon Inc. | |||||||||||||||||||||||
Full Title: A Multicenter, Open-Label, Parallel, Phase 1b/2a Study of PLX2853 in Combination with Abiraterone Acetate and Prednisone and Phase 1b/2a Study of PLX2853 in Combination with Olaparib in Subjects wi... | |||||||||||||||||||||||
Medical condition: Metastatic Castration-Resistant Prostate Cancer (mCRPC) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002431-53 | Sponsor Protocol Number: IB2021-03 | Start Date*: 2022-09-23 | |||||||||||
Sponsor Name:Institut Bergonié | |||||||||||||
Full Title: A RANDOMIZED NON-COMPARATIVE PHASE II MULTICENTRIC TRIAL ON SHORT TERM DAROLUTAMIDE (ODM-201) CONCOMITANT TO RADIATION THERAPY FOR PATIENTS WITH INTERMEDIATE UNFAVORABLE RISK PROSTATE CANCER | |||||||||||||
Medical condition: Prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001632-13 | Sponsor Protocol Number: 2008-001632-13 | Start Date*: 2009-02-24 | |||||||||||
Sponsor Name:LEGA ITALIANA PER LA LOTTA CONTRO I TUMORI | |||||||||||||
Full Title: Continuous vs intermittent weekly docetaxel in the elderly patient with advanced and hormone-refractory prostate cancer: a randomized phase II study | |||||||||||||
Medical condition: Advanced and hormone-refractory prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003680-22 | Sponsor Protocol Number: BC1-04 | Start Date*: 2006-02-01 | |||||||||||
Sponsor Name:Algeta ASA | |||||||||||||
Full Title: A double blind, randomised, dose finding, repeat dose, phase II, multicentre study of Alpharadin TM for the treatment of patients with hormone refractory prostate cancer and skeletal metastases. | |||||||||||||
Medical condition: Hormone refractory prostate cancer and skeletal metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004178-27 | Sponsor Protocol Number: KS-01 | Start Date*: 2012-02-19 | |||||||||||||||||||||
Sponsor Name:Karolinska University Hospital | |||||||||||||||||||||||
Full Title: A Randomized, Open Label, Multicenter, Phase II, 2-Arm Study comparing the conventional 3 weekly schedule of Jevtana (Cabazitaxel) with a weekly regimen in patients with Metastastic Castration Resi... | |||||||||||||||||||||||
Medical condition: Metastatic Castration Resistant Prostate Cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: SE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001634-28 | Sponsor Protocol Number: MDV3100-13(C3431004) | Start Date*: 2015-04-24 | |||||||||||
Sponsor Name:Medivation, Inc., a wholly owned subsidiary of Pfizer Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressi... | |||||||||||||
Medical condition: Patients with high-risk nonmetastatic prostate cancer progressing after definitive therapy (radical prostatectomy or radiotherapy or both). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: SE (Trial now transitioned) FI (Trial now transitioned) AT (Trial now transitioned) NL (Trial now transitioned) ES (Ongoing) FR (Trial now transitioned) DK (Trial now transitioned) DE (Completed) SK (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003740-39 | Sponsor Protocol Number: URO-CHUAC-BPSat-001. | Start Date*: 2016-04-12 | |||||||||||
Sponsor Name:Jose Luis Ponce Díaz-Reixa | |||||||||||||
Full Title: Open randomized clinical trial to examine individual pain tolerance in the use of two anesthetic techniques to perform saturation prostate biopsy . | |||||||||||||
Medical condition: Prostate biopsy anesthesia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003652-21 | Sponsor Protocol Number: 2019-23 | Start Date*: 2020-01-23 | |||||||||||
Sponsor Name:OSPEDALE CLASSIFICATO EQUIPARATO SACRO CUORE DON CALABRIA - PRESIDIO OSPEDALIERO ACCREDITATO | |||||||||||||
Full Title: Interventional two arms open-label study for evaluating the diagnostic performance of PET PSMA in patients affected by biochemical recurrent prostate cancer. | |||||||||||||
Medical condition: Biochemical recurrent prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001746-34 | Sponsor Protocol Number: 56021927PCR3011 | Start Date*: 2019-04-02 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy | |||||||||||||
Medical condition: High-risk localized or locally advanced prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Trial now transitioned) DE (Trial now transitioned) NL (Trial now transitioned) PL (Trial now transitioned) ES (Ongoing) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020681-16 | Sponsor Protocol Number: LO-10-01 | Start Date*: 2010-10-12 | |||||||||||
Sponsor Name:Lunamed Operations AG | |||||||||||||
Full Title: A PILOT STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND EFFICACY OF A DAILY DOSE OF 500MG. LU901 (4PHENYL-BUTYRATE, CONTROLLED RELEASE TABLETS) IN ADDITION TO STANDARD HORMONAL TREATMENT IN PATIE... | |||||||||||||
Medical condition: Patients suffering from prostate carcinoma with progression under first line hormonal treatment. Patients entering the study should have a life expectancy prognosis of at least 6 months. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018311-15 | Sponsor Protocol Number: GE-148-003 | Start Date*: 2010-05-21 |
Sponsor Name:GE Healthcare Limited | ||
Full Title: A Phase 2, Open-label Study to Assess the Uptake and Retention and Safety of GE 148 (18F) Injection in Subjects with Biopsy-proven Prostate Cancer who are Scheduled for Radical Prostatectomy | ||
Medical condition: Detection of abnormal amino acid transport using Positron Emission Tomography (PET) in malignancy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: SE (Prematurely Ended) FI (Prematurely Ended) DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021128-92 | Sponsor Protocol Number: CABAZ_C_05331 | Start Date*: 2010-11-11 | |||||||||||
Sponsor Name:sanofi-aventis groupe | |||||||||||||
Full Title: MULTICENTRE, SINGLE-ARM, OPEN LABEL CLINICAL TRIAL INTENDED TO PROVIDE EARLY ACCESS TO CABAZITAXEL IN PATIENTS WITH METASTATIC HORMONE REFRACTORY PROSTATE CANCER PREVIOUSLY TREATED WITH A DOCETAX... | |||||||||||||
Medical condition: Metastatic hormone refractory prostate cancer previously treated with a docetaxel-containing regimen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) BE (Completed) DK (Completed) ES (Completed) IT (Completed) SE (Completed) FI (Completed) AT (Completed) PT (Completed) HU (Completed) IE (Completed) BG (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003046-17 | Sponsor Protocol Number: BAY88-8223/16506 | Start Date*: 2013-10-25 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A re-treatment safety study of radium-223 dichloride in subjects with castration-resistant prostate cancer with bone metastases who received an initial course of six doses of radium-223 dichloride ... | |||||||||||||
Medical condition: Castration Resistant Prostate cancer patients with bone metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: SE (Completed) NO (Completed) FI (Completed) IT (Completed) ES (Completed) GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003461-34 | Sponsor Protocol Number: UR1840 | Start Date*: 2019-07-09 | |||||||||||||||||||||
Sponsor Name:Department of Oncology, Herlev & Gentofte Hospital | |||||||||||||||||||||||
Full Title: Randomised phase 2 trial of stereotactic body radiation therapy, SBRT, in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer | |||||||||||||||||||||||
Medical condition: metastatic castration-resistant prostate cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001318-18 | Sponsor Protocol Number: 2135/2006 | Start Date*: 2006-07-21 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: PHASE II STUDY OF BAY 43-9006, DOCETAXEL AND PREDNISONE IN METASTATIC PROSTATE CANCER | |||||||||||||
Medical condition: Patients with advanced hormone refractory prostate carcinoma without docetaxel pretreatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005607-33 | Sponsor Protocol Number: 411-IP-06-01-0000/IPSS-D039 | Start Date*: 2008-02-08 | |||||||||||
Sponsor Name:KOMINOX USA, Inc. | |||||||||||||
Full Title: A Clinical Phase II Study in Patients with Prostate Cancer and Bone Metastases with KML001 (KOMINOX®) | |||||||||||||
Medical condition: Prostate Cancer Metastatic | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004685-18 | Sponsor Protocol Number: PSMA-PROSTAPET | Start Date*: 2020-07-28 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA | |||||||||||||
Full Title: Evaluation of diagnostic accuracy of [68Ga]Ga-PSMA-11 PET/CT in primary staging of Intermediate and High Risk Prostatic Cancer in men newly diagnosed | |||||||||||||
Medical condition: Men with histo-pathological confirmation of PCa with intermediate or high-risk disease according to 2019 Prostate Cancer EAU Guidelines Risk Group Stratification | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002407-25 | Sponsor Protocol Number: 16996 | Start Date*: 2014-11-25 | |||||||||||||||||||||
Sponsor Name:Bayer AG | |||||||||||||||||||||||
Full Title: A Phase 4 long-term follow-up study to define the safety profile of radium-223 dichloride | |||||||||||||||||||||||
Medical condition: Castrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer, breast cancer or multiple myeloma patients with bone metastasis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) SE (Completed) ES (Completed) FR (Completed) BE (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) FI (Completed) PL (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001891-35 | Sponsor Protocol Number: D4200C00080 | Start Date*: 2007-06-22 | |||||||||||
Sponsor Name:AstraZeneca SAS | |||||||||||||
Full Title: A randomized, double-blind phase II trial to assess the efficacy and safety of bicalutamide (Casodex® ) associated to ZD6474 (Zactima™ ) or to placebo in patients with castration-refractory metasta... | |||||||||||||
Medical condition: Metastatic prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
